GS

Guvalapalli Sandeep Kumar

Active Director Director DIN 11540348
DIN 11540348 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Guvalapalli Sandeep Kumar

Data last updated:

Guvalapalli Sandeep Kumar is a Director at Wizqen Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11540348
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Feb 20262026Active

Board colleagues of Guvalapalli Sandeep Kumar

Directorship timeline

Open interactive timeline →
Wizqen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Guvalapalli Sandeep Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Guvalapalli Sandeep Kumar

Guvalapalli Sandeep Kumar currently holds 1 directorship: Wizqen Pharmaceuticals Private Limited (Director, since 11 Feb 2026).

Guvalapalli Sandeep Kumar was first appointed on 11 Feb 2026 as Director at Wizqen Pharmaceuticals Private Limited.

The current boards of Guvalapalli Sandeep Kumar's companies include Guvvalapalli Kishor Kumar (Wizqen Pharmaceuticals Private Limited), Kirana Mallikarjunappa (Wizqen Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available